Competing interests are all over this publication as author... Justin Stebbing in total has 26.
"Results of the Open and enrolling trials of Maraviroc & BMS-813160 will (solidify) the value of the CCR/L5 axis as a therapeutic Target in advanced CRC...Ohm ???